Cholera medical therapy

Jump to navigation Jump to search

Cholera Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Cholera from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications, and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

X Ray

CT

MRI

Other diagnostic studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Case Studies

Case #1

Cholera medical therapy On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Cholera medical therapy

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Cholera medical therapy

CDC on Cholera medical therapy

Cholera medical therapy in the news

Blogs on Cholera medical therapy

Directions to Hospitals Treating Cholera

Risk calculators and risk factors for Cholera medical therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editors-In-Chief: Priyamvada Singh, MBBS [2]

Overview

In most cases, cholera can be successfully treated with oral rehydration therapy (ORT), which is highly effective, safe, and simple to administer. In severe cases with significant dehydration, intravenous rehydration may be necessary. Ringer's lactate is the preferred solution, often with added potassium.[1]

  • Fluoroquinolones, such as norfloxacin, also may be used, but resistance has been reported.[2]
  • Young children: erythromycin 12,5 mg/kg 4 time/day for 3 days
    • for children below 6 months of age: 10 mg daily for 10 days add zinc
    • for children 6 months to 5 years of age: 20mg daily for 10 days add zinc
  • In many areas of the world, antibiotic resistance is increasing. Testing for resistance during an outbreak can help determine appropriate future choices. In Bangladesh, for example, most cases are resistant to tetracycline, trimethoprim-sulfamethoxazole, and erythromycin. Rapid diagnostic assay methods are available for the identification of multiple drug-resistant cases.[3] New generation antimicrobials have been discovered which are effective against in in vitro studies.[4]

Nutrition

  • Proper attention on nutrition is important as patients with cholera often ignore nutrition due to diarrhea and vomiting. This may lead to hypoglycemia and associated complications like seizure, coma and even death in pediatrics population.
  • Provide frequent small meals with familiar foods during the first two days rather than infrequent large meals
  • Breastfeeding of infants and young children should continue

References

  1. Krishna BV, Patil AB, Chandrasekhar MR (2006). "Fluoroquinolone-resistant Vibrio cholerae isolated during a cholera outbreak in India". Trans. R. Soc. Trop. Med. Hyg. 100 (3): 224–6. doi:10.1016/j.trstmh.2005.07.007. PMID 16246383. Unknown parameter |month= ignored (help)
  2. Mackay IM (editor) (2007). Real-Time PCR in microbiology: From diagnosis to characterization. Caister Academic Press. ISBN 978-1-904455-18-9.
  3. Ramamurthy T (2008). "Antibiotic resistance in Vibrio cholerae". Vibrio cholerae: Genomics and molecular biology. Caister Academic Press. ISBN 978-1-904455-33-2.

External links


Template:WikiDoc Sources